Carl Zeiss Meditec Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Carl Zeiss Meditec de 11.4% y 8.9% por año respectivamente. Se prevé que el BPA crezca en un 11.7% al año. Se espera que la rentabilidad financiera sea de 13.7% en 3 años.

Información clave

13.6%

Tasa de crecimiento de los beneficios

13.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.7%
Tasa de crecimiento de los ingresos	10.2%
Rentabilidad financiera futura	13.9%
Cobertura de analistas	Good
Última actualización	10 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11

Recent updates

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11

Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Feb 12

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jan 29

What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Dec 08

Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Nov 08

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Oct 24

Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Sep 24

Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Sep 08

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jul 24

We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Jun 19

Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Jun 06

Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

May 22

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Apr 19

Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Feb 26

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 10

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Jan 28

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Jan 12

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Dec 29

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Dec 14

What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Nov 04

Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)

Oct 18

Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist

Sep 12

Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly

Aug 25

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes

May 30

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Feb 27

Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall

Feb 08

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Dec 12

Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

Nov 06

If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

Sep 06

Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)

Aug 08

Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being

May 21

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

May 18

Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal

Apr 28

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price

Mar 09

How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?

Feb 16

What Type Of Shareholders Own The Most Number of Carl Zeiss Meditec AG (ETR:AFX) Shares?

Jan 30

Previsiones de crecimiento de beneficios e ingresos

XTRA:AFX - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2026	2,748	366	331	438	13
9/30/2025	2,535	319	290	383	15
9/30/2024	2,217	251	222	335	10
3/31/2024	2,062	261	122	263	N/A
12/31/2023	2,094	277	N/A	N/A	N/A
9/30/2023	2,089	290	137	251	N/A
6/30/2023	2,080	308	N/A	N/A	N/A
3/31/2023	2,022	278	63	162	N/A
12/31/2022	1,963	307	N/A	N/A	N/A
9/30/2022	1,903	294	106	188	N/A
6/30/2022	1,781	245	N/A	N/A	N/A
3/31/2022	1,735	264	207	285	N/A
12/31/2021	1,688	228	N/A	N/A	N/A
9/30/2021	1,647	236	297	363	N/A
6/30/2021	1,566	235	N/A	N/A	N/A
3/31/2021	1,388	159	240	290	N/A
12/31/2020	1,335	130	N/A	N/A	N/A
9/30/2020	1,335	122	134	179	N/A
6/30/2020	1,400	120	N/A	N/A	N/A
3/31/2020	1,507	166	132	171	N/A
12/31/2019	1,505	170	N/A	N/A	N/A
9/30/2019	1,459	160	173	220	N/A
6/30/2019	1,382	153	N/A	N/A	N/A
3/31/2019	1,334	129	195	242	N/A
12/31/2018	1,310	127	N/A	N/A	N/A
9/30/2018	1,281	126	152	187	N/A
6/30/2018	1,251	124	N/A	N/A	N/A
3/31/2018	1,216	129	17	56	N/A
12/31/2017	1,205	132	N/A	N/A	N/A
9/30/2017	1,190	134	N/A	38	N/A
6/30/2017	1,154	123	N/A	N/A	N/A
3/31/2017	1,135	112	N/A	85	N/A
12/31/2016	1,106	113	N/A	N/A	N/A
9/30/2016	1,088	98	N/A	112	N/A
6/30/2016	1,090	78	N/A	132	N/A
3/31/2016	1,083	80	N/A	96	N/A
12/31/2015	1,062	61	N/A	73	N/A
9/30/2015	1,040	62	N/A	57	N/A
6/30/2015	984	70	N/A	34	N/A
3/31/2015	946	66	N/A	44	N/A
12/31/2014	938	73	N/A	60	N/A
9/30/2014	909	75	N/A	63	N/A
6/30/2014	931	83	N/A	74	N/A
3/31/2014	924	89	N/A	69	N/A
12/31/2013	900	89	N/A	52	N/A
9/30/2013	906	92	N/A	65	N/A
6/30/2013	880	86	N/A	63	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (11.4% al año) de AFX es superior a la tasa de ahorro (0.6%).

Beneficios vs. Mercado: Se prevé que los beneficios (11.4% al año) de AFX crezcan menos que el mercado German (14% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de AFX crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (8.9% al año) de AFX crezcan más rápidamente que los del mercado German (5.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 8.9% al año) de AFX crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de AFX sea baja dentro de 3 años (13.7%).

Carl Zeiss Meditec Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Price target decreased by 9.6% to €99.15

Price target decreased by 10% to €114

Carl Zeiss Meditec AG Reaffirms Earning Guidance for 2022

Carl Zeiss Meditec AG Reaffirms Earnings Guidance for the Year 2021/22

Price target increased to €164

Recent updates

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Upcoming dividend of €1.10 per share

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

First quarter 2024 earnings: EPS exceeds analyst expectations

Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Carl Zeiss Meditec AG to Report First Half, 2024 Results on May 08, 2024

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG, Annual General Meeting, Mar 21, 2024

Carl Zeiss Meditec AG Announces U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS

Full year 2023 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 15%

What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Price target decreased by 9.6% to €99.15

Now 20% undervalued after recent price drop

Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Now 21% undervalued after recent price drop

ZEISS Reimagined the Iconic Pentero Platform for Digital Age

Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Price target decreased by 10% to €114

Third quarter 2023 earnings: EPS exceeds analyst expectations

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Upcoming dividend of €1.10 per share at 0.8% yield

Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Full year 2022 earnings: EPS and revenues exceed analyst expectations

What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Carl Zeiss Meditec AG to Report Q1, 2023 Results on Feb 10, 2023

Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)

Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist

Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes

Carl Zeiss Meditec AG Reaffirms Earning Guidance for 2022

Carl Zeiss Meditec AG (XTRA:AFX) acquired Kogent Surgical, LLC and Katalyst Surgical, LLC.

Upcoming dividend of €0.90 per share

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

First quarter 2022 earnings: EPS misses analyst expectations

Carl Zeiss Meditec AG Reaffirms Earnings Guidance for the Year 2021/22

Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Full year 2021 earnings: EPS misses analyst expectations

Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

Investor sentiment deteriorated over the past week

If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

Price target increased to €164

Price target increased to €162

Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)

Price target increased to €150

Consensus EPS estimates increase to €2.81

Consensus EPS estimates increase to €2.54

Price target increased to €139

Upcoming dividend of €0.50 per share

Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems